Impax Laboratories, Inc.
Impax Laboratories Confirms Patent Challenge Relating to ORACEA(R) Delayed-Release Capsules, 40mg
Published in Law and Health Weekly, October 10th, 2009
Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of ORACEA® with the U.S. Food & Drug Administration ("FDA"). Following receipt of the notice from the FDA that Impax's ANDA had been accepted for filing, Impax notified the New Drug Application holder and patent owners of its paragraph IV certification.
On September 18, 2009, The Research Foundation of State University of New...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- 3DIcon Corporation
3DIcon Retains Trontz Public Relations as Agency of Record - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with Digilink Technology, Inc. - Acacia Research Corporation
Acacia Subsidiary Enters into Settlement and License Agreement with Mercedes-Benz USA - Alcohol Monitoring Systems, Inc.
Punish the Cars or Deal With the People? - American College of Physicians
Internists' new paper identifies and analyzes key drivers of health care costs - American Veterinary Medical Association
U.S. Senators Introduce Veterinary Services Legislation - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
